106 related articles for article (PubMed ID: 11888169)
1. Cross-protection against challenge by intravenous Escherichia coli verocytotoxin 1 (VT1) in rabbits immunized with VT2 toxoid.
Ludwig K; Karmali MA; Smith CR; Petric M
Can J Microbiol; 2002 Jan; 48(1):99-103. PubMed ID: 11888169
[TBL] [Abstract][Full Text] [Related]
2. Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.
Bielaszewska M; Clarke I; Karmali MA; Petric M
Infect Immun; 1997 Jul; 65(7):2509-16. PubMed ID: 9199412
[TBL] [Abstract][Full Text] [Related]
3. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
Bast DJ; Brunton JL; Karmali MA; Richardson SE
Infect Immun; 1997 Jun; 65(6):2019-28. PubMed ID: 9169727
[TBL] [Abstract][Full Text] [Related]
4. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
Wen SX; Teel LD; Judge NA; O'Brien AD
Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455
[TBL] [Abstract][Full Text] [Related]
5. Protection against verocytotoxin in mice induced by liposome-coupled verocytotoxin.
Naito S; Horino A; Komiya T; Fukuda Y; Takahashi M; Ami Y; Suzaki Y; Satoh S; Gondaira F; Sugiyama J; Nakano Y; Mori M; Awai K; Nishinohara S; Komuro K; Uchida T
Int Arch Allergy Immunol; 1997 Nov; 114(3):293-7. PubMed ID: 9363912
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing activity of bovine colostral antibody against verotoxin derived from enterohemorrhagic Escherichia coli O157:H7 in mice.
Kuribayashi T; Seita T; Fukuyama M; Furuhata K; Honda M; Matsumoto M; Seguchi H; Yamamoto S
J Infect Chemother; 2006 Oct; 12(5):251-6. PubMed ID: 17109087
[TBL] [Abstract][Full Text] [Related]
7. Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1.
Ishikawa S; Kawahara K; Kagami Y; Isshiki Y; Kaneko A; Matsui H; Okada N; Danbara H
Infect Immun; 2003 Jun; 71(6):3235-9. PubMed ID: 12761104
[TBL] [Abstract][Full Text] [Related]
8. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.
Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD
Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486
[TBL] [Abstract][Full Text] [Related]
9. LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E. coli strains.
Zhu C; Feng S; Yang Z; Davis K; Rios H; Kaper JB; Boedeker EC
Vaccine; 2007 Feb; 25(10):1884-92. PubMed ID: 17234305
[TBL] [Abstract][Full Text] [Related]
10. Protection of piglets against Edema disease by maternal immunization with Stx2e toxoid.
Oanh TK; Nguyen VK; De Greve H; Goddeeris BM
Infect Immun; 2012 Jan; 80(1):469-73. PubMed ID: 22083704
[TBL] [Abstract][Full Text] [Related]
11. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
[TBL] [Abstract][Full Text] [Related]
12. Experimental verocytotoxemia in rabbits.
Richardson SE; Rotman TA; Jay V; Smith CR; Becker LE; Petric M; Olivieri NF; Karmali MA
Infect Immun; 1992 Oct; 60(10):4154-67. PubMed ID: 1398926
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
[TBL] [Abstract][Full Text] [Related]
14. Immunization of pigs with a purified Shiga-like toxin II variant toxoid.
MacLeod DL; Gyles CL
Vet Microbiol; 1991 Nov; 29(3-4):309-18. PubMed ID: 1837635
[TBL] [Abstract][Full Text] [Related]
15. Effect of verocytotoxins (Shiga-like toxins) on human neutrophils in vitro.
Holle JU; Williams JM; Harper L; Savage CO; Taylor CM
Pediatr Nephrol; 2005 Sep; 20(9):1237-44. PubMed ID: 15947986
[TBL] [Abstract][Full Text] [Related]
16. A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2.
Tsuji T; Shimizu T; Sasaki K; Tsukamoto K; Arimitsu H; Ochi S; Shimizu T; Taniguchi K; Noda M; Neri P; Mori H
Vaccine; 2008 Apr; 26(17):2092-9. PubMed ID: 18387720
[TBL] [Abstract][Full Text] [Related]
17. The nature of immunity to the Escherichia coli Shiga toxins (verocytotoxins) and options for toxoid immunization.
Karmali MA
Jpn J Med Sci Biol; 1998; 51 Suppl():S26-35. PubMed ID: 10211434
[No Abstract] [Full Text] [Related]
18. Neutralization receptor-based immunoassay for detection of neutralizing antibodies to Escherichia coli verocytotoxin 1.
Boulanger J; Petric M; Lingwood C; Law H; Roscoe M; Karmali M
J Clin Microbiol; 1990 Dec; 28(12):2830-3. PubMed ID: 2280020
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing Anti-Heat-Stable Toxin (STa) Antibodies Derived from Enterotoxigenic Escherichia coli Toxoid Fusions with STa Proteins Containing N12S, L9A/N12S, or N12S/A14T Mutations Show Little Cross-Reactivity with Guanylin or Uroguanylin.
Duan Q; Huang J; Xiao N; Seo H; Zhang W
Appl Environ Microbiol; 2018 Jan; 84(2):. PubMed ID: 29079628
[TBL] [Abstract][Full Text] [Related]
20. A novel Salmonella strain inactivated by a regulated autolysis system and expressing the B subunit of Shiga toxin 2e efficiently elicits immune responses and confers protection against virulent Stx2e-producing Escherichia coli.
Won G; Kim TH; Lee JH
BMC Vet Res; 2017 Feb; 13(1):40. PubMed ID: 28143511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
